<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Venus Remedies Limited — News on 6ix</title>
<link>https://6ix.com/company/venus-remedies-limited</link>
<description>Latest news and press releases for Venus Remedies Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 05 Nov 2024 14:38:43 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/venus-remedies-limited" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683650e578dffbe2df1557ce.webp</url>
<title>Venus Remedies Limited</title>
<link>https://6ix.com/company/venus-remedies-limited</link>
</image>
<item>
<title>Press Release Nov 05 2024</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-nov-05-2024-17</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-nov-05-2024-17</guid>
<pubDate>Tue, 05 Nov 2024 14:38:43 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated November 05, 2024, titled "Venus Remedies Expands Reach in ASEAN Region with Malaysian PIC/S GMP Approval for Pre-Filled Syringe Facility".</description>
</item>
<item>
<title>Press Release Mar 11 2024</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-mar-11-2024-14</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-mar-11-2024-14</guid>
<pubDate>Mon, 11 Mar 2024 19:01:33 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated March 11, 2024, titled "Venus Remedies Ltd secured Good Manufacturing Practices (GMP) approval from the United Nations Children's Fund (UNICEF)".</description>
</item>
<item>
<title>Press Release Mar 06 2024</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-mar-06-2024-9</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-mar-06-2024-9</guid>
<pubDate>Wed, 06 Mar 2024 14:22:49 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated March 06, 2024, titled "Venus Remedies awarded its first incentive of Rs.7.50 cr. under PLI scheme".</description>
</item>
<item>
<title>Press Release Dec 20 2023</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-dec-20-2023-2</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-dec-20-2023-2</guid>
<pubDate>Wed, 20 Dec 2023 16:07:11 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated December 20, 2023, titled "Press Release- Venus Remedies R3SET Takes Strategic Leap into Wellness with Holistic Health Innovations".</description>
</item>
<item>
<title>Press Release Dec 01 2023</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-dec-01-2023-12</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-dec-01-2023-12</guid>
<pubDate>Fri, 01 Dec 2023 16:54:09 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated December 01, 2023, titled "Venus Remedies Granted Market Authorizations in Saudi Arabia and Philippines ".</description>
</item>
<item>
<title>Press Release Nov 06 2023</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-nov-06-2023-28</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-nov-06-2023-28</guid>
<pubDate>Mon, 06 Nov 2023 15:21:00 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated November 06, 2023, titled "Venus Remedies Limited Secures the Reputable "Three Star Export House" Certificate from the Government of India".</description>
</item>
<item>
<title>Press Release Nov 01 2023</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-nov-01-2023-31</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-nov-01-2023-31</guid>
<pubDate>Wed, 01 Nov 2023 13:24:04 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated November 01, 2023, titled "Venus Earns Prestigious FICCI Healthcare Award 2023 for Pioneering 'Organ-on-a-Chip' Research Model".</description>
</item>
<item>
<title>Press Release Oct 26 2023</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-oct-26-2023-23</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-oct-26-2023-23</guid>
<pubDate>Thu, 26 Oct 2023 13:38:19 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated October 26, 2023, titled "Venus Remedies Granted Market Authorization for Bleomycin 15,000 IU in the United Kingdom".</description>
</item>
<item>
<title>Press Release Oct 20 2023</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-oct-20-2023-26</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-oct-20-2023-26</guid>
<pubDate>Fri, 20 Oct 2023 14:01:56 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated October 20, 2023, titled "Venus Remedies Earns Prestigious REO Certification from CII for Second Consecutive Year".</description>
</item>
<item>
<title>Press Release Oct 16 2023</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-oct-16-2023-23</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-oct-16-2023-23</guid>
<pubDate>Mon, 16 Oct 2023 13:35:53 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated October 16, 2023, titled "Venus Remedies consolidates in ASEAN, gets marketing approval for six chemotherapy drugs from the Philippines".</description>
</item>
<item>
<title>Press Release Oct 12 2023</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-oct-12-2023-11</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-oct-12-2023-11</guid>
<pubDate>Thu, 12 Oct 2023 19:12:22 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated October 12, 2023, titled "Venus Remedies Limited Expands Global Reach with the Launch of Elores in Ecuador".</description>
</item>
<item>
<title>Press Release Sep 21 2023</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-sep-21-2023-14</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-sep-21-2023-14</guid>
<pubDate>Thu, 21 Sep 2023 21:11:16 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated September 21, 2023, titled "Venus Remedies Limited Honored with Best Working Conditions Award 2022".</description>
</item>
<item>
<title>Press Release Sep 20 2023</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-sep-20-2023-10</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-sep-20-2023-10</guid>
<pubDate>Wed, 20 Sep 2023 14:30:41 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated September 20, 2023, titled "Venus Remedies extends its oncology portfolio in South Eastern Europe with Serbian marketing approval for gemcitabine and docetaxel.".</description>
</item>
<item>
<title>Press Release Sep 13 2023</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-sep-13-2023-9</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-sep-13-2023-9</guid>
<pubDate>Wed, 13 Sep 2023 21:20:17 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated September 13, 2023, titled "VENUS REMEDIES LIMITED ATTAINS THE DEPARTMENT OF SCIENTIFIC AND INDUSTRIAL RESEARCH (DSIR) REGISTRATION FOR CUSTOMS DUTY EXEMPTION".</description>
</item>
<item>
<title>Press Release Aug 28 2023</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-aug-28-2023-7</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-aug-28-2023-7</guid>
<pubDate>Mon, 28 Aug 2023 15:41:09 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated August 28, 2023, titled "Venus Remedies on expansion spree in Gulf, gets Saudi marketing approval for Enoxaparin in PFS".</description>
</item>
<item>
<title>Press Release Aug 17 2023</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-aug-17-2023-12</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-aug-17-2023-12</guid>
<pubDate>Thu, 17 Aug 2023 16:03:15 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated August 17, 2023, titled "Press Release- Venus Remedies launches its flagship R&D drug Elores in Oman.".</description>
</item>
<item>
<title>Press Release Jul 31 2023</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-jul-31-2023-16</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-jul-31-2023-16</guid>
<pubDate>Mon, 31 Jul 2023 14:47:05 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated July 31, 2023, titled "Venus Remedies oncology wing product registrations go up to 506 with marketing approvals from four more countries.".</description>
</item>
<item>
<title>Press Release Jul 05 2023</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-jul-05-2023-11</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-jul-05-2023-11</guid>
<pubDate>Wed, 05 Jul 2023 14:45:08 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated July 05, 2023, titled "Venus Remedies oncology wing on expansion spree with marketing approvals from four key markets.".</description>
</item>
<item>
<title>Press Release Jun 22 2023</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-jun-22-2023-5</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-jun-22-2023-5</guid>
<pubDate>Thu, 22 Jun 2023 14:56:48 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated Jun 22, 2023, titled "VENUS REMEDIES BAGS APPROVAL TO MARKET MEROPENEM, ITS BLOCKBUSTER GENERIC DRUG, IN SPAIN".</description>
</item>
<item>
<title>Press Release Jun 07 2023</title>
<link>https://6ix.com/company/venus-remedies-limited/news/press-release-jun-07-2023-9</link>
<guid isPermaLink="true">https://6ix.com/company/venus-remedies-limited/news/press-release-jun-07-2023-9</guid>
<pubDate>Wed, 07 Jun 2023 14:30:47 GMT</pubDate>
<description>Venus Remedies Limited has informed the Exchange regarding a press release dated Jun 07, 2023, titled "Venus Remedies Awarded Ukrainian GMP Approval for Its Carbapenem, Oncology Parenteral Facilities.".</description>
</item>
</channel>
</rss>